Clinical Trial Update: Pregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for pregabalin in postherpetic neuralgia (PHN) with completed status and results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Postherpetic Neuralgia ( PHN ) | Phase 4 | Status: COMPLETED | Results posted: 2015-05-22